J. Yang et al.
European Journal of Pharmacology 888 (2020) 173396
In this study, a series of bischalcone analogs are synthesized ac-
MHz, (CD3)2CO), δ 8.12 (d, J = 9.0 Hz, 4H), 7.97 (d, J = 15.9 Hz, 2H),
7.92 (s, 4H), 7.77 (d, J = 15.9 Hz, 2H), 6.99 (d, J = 9.0 Hz, 4H); 13C NMR
(75 MHz, CDCl3), δ 187.0, 162.2, 157.8, 141.8, 136.6, 131.2, 129.1,
123.0, 115.4.
cording to the Aldol condensation protocol (Scheme 1). Thus we focus
on the cytotoxicity and explore the anticancer mechanism against
human lung cancer A549 cells.
(2E, 2′E)-3,3′-(1,4-phenylene)bis(1-(2-methoxyphenyl)prop-2-en-1-
one (1d). Yield: 42.5%, light yellow solid; mp 150-152 ◦C, 1H NMR (400
MHz, CDCl3), δ 7.65-7.60 (m, 8H), 7.51-7.47 (m, 2H), 7.45 (d, J = 16 Hz,
2H), 7.07 (t, J = 8.0 Hz, 2H), 7.02 (d, J = 8.0, 2.4 Hz, 2H), 3.92 (s, 6H);
13C NMR (100 MHz, CDCl3), δ 192.6, 158.2, 141.9, 136.9, 133.1, 130.4,
129.1, 128.8, 127.8, 120.8, 111.6, 55.8, 55.7.
2. Materials and methods
2.1. Materials
Roswell Park Memorial Institute (RPMI)-1640 was from Hyclone. 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT),
rhodamine 123, 2´,7´-dichlorofluorescein diacetate, the reduced (GSH)
and oxidized (GSSG) glutathione, 2-vinylpyridine (97%) and thio-
barbituric acid were obtained from Beyotime. Radio Immunoprecipita-
tion Assay (RIPA) buffer, 50*Cooktail proteinase inhibitor, GAPDH, the
primary antibodies and HRP-labeled secondary antibodies were pur-
chased from Servicebio. Annexin V-FITC/PI apoptosis detection kit was
purchased from BD Biosciences. Substituted acetophenone, 1,4-phtha-
laldehyde and curcumin were from EnergyChemical. All other chem-
icals were of the highest quality available.
(2E, 2′E)-3,3′-(1,4-phenylene)bis(1-(3-methoxyphenyl)prop-2-en-1-
one (1e). Yield: 50.6%, yellow powder; mp 180-182 ◦C, 1H NMR (400
MHz, CDCl3), δ 7.84 (d, J = 16 Hz, 2H), 7.70 (s, 4H), 7.63-7.55 (m, 6H),
7.45 (t, J = 8.0 Hz, 2H), 7.17 (dd, J = 8.0, 2.4 Hz, 2H), 3.90 (s, 6H); 13
C
NMR (100 MHz, CDCl3), δ 189.9, 159.9, 143.5, 139.4, 136.9, 129.6,
129.0, 123.1, 121.1, 119.4, 112.9, 55.5.
(2E, 2′E)-3,3′-(1,4-phenylene)bis(1-(4-methoxyphenyl)prop-2-en-1-
one (1f). Yield: 55.8%, yellow powder; mp 245-248 ◦C; 1H NMR (300
MHz, (CDCl3), δ 8.05 (d, J = 8.4 Hz, 4H), 7.80 (d, J = 15.9 Hz, 2H), 7.68
(s, 4H), 7.59 (d, J = 15.9 Hz, 2H), 7.00 (d, J = 8.4 Hz, 4H), 3.90 (s, 6H);
13C NMR (75 MHz, CDCl3), δ 188.4, 163.5, 142.7, 136.9, 130.9, 130.8,
128.8, 122.8, 114.0, 113.9, 55.5.
2.2. Synthesis of the curcumin analogs
(2E, 2′E)-3,3′-(1,4-phenylene)bis(1-(2-fluorinephenyl)prop-2-en-1-
one (1g).
2.2.1. General procedure for the synthesis of 1a-1i
Yield: 56.2%, yellow powder; mp 135-138 ◦C; 1H NMR (500 MHz,
(CDCl3), δ 7.82 (t, J = 8.0 Hz, 2H), 7.73 (d, J = 16.0 Hz, 2H), 7.67 (s,
4H), 7.53-7.56 (m, 2H), 7.44 (d, J = 16.0 Hz, 2H); 7.26 (d, J = 8.0 Hz,
2H); 7.17 (t, J = 8.0 Hz, 2H).
The bischalcone analogs were synthesized according to the published
stirred solution of 1,4-phthalaldehyde (5 mmol) and relevant aceto-
phenone (10 mmol) in ethanol (20 ml) at 0 ◦C. After 24 h stirring at room
temperature, distilled water and 10% hydrochloric acid solution were
added for total precipitation of the compounds. Then the crude products
were purified with a silica gel column. Their structures were confirmed
by 1H and 13C NMR spectroscopy.
(2E, 2′E)-3,3′-(1,4-phenylene)bis(1-(3-fluorinephenyl)prop-2-en-1-
one (1h).
Yield: 61.5%, yellow powder; mp 141-144 ◦C; 1H NMR (500 MHz,
(CDCl3), δ 8.07-8.10 (m, 4H), 7.81 (d, J = 16.0 Hz, 2H), 7.71 (s, 4H),
7.55 (d, J = 16.0 Hz, 2H); 7.18 (d, J = 8.0 Hz, 4H).
(2E, 2′E)-3,3′-(1,4-phenylene)bis(1-(4-fluorinephenyl)prop-2-en-1-
one (1i).
(2E, 2′E)-3,3′-(1,4-phenylene)bis(1-(2-hydroxylphenyl)prop-2-en-1-
one (1a). Yield: 44.2%; Yellow solid; m.p.: 228-231 ◦C, 1H NMR (400
MHz, d6-DMSO), δ 12.48 (s, 2H), 8.30 (dd, J = 8.0, 1.6 Hz, 2H), 8.17 (d,
J = 16 Hz, 2H), 8.03 (d, J = 8.0 Hz, 4H), 7.90 (d, J = 16 Hz, 2H), 7.61-
7.57 (m, 2H), 7.05-7.03 (m, 4H); 13C NMR (100 MHz, CDCl3), δ 193.9,
162.2, 144.0, 137.1, 136.8, 131.4, 130.1, 123.6, 121.4, 119.6, 118.2.
(2E, 2′E)-3,3′-(1,4-phenylene)bis(1-(3-hydroxylphenyl)prop-2-en-1-
one (1b). Yield: 51.6%, light yellow solid; m.p.: 244-246 ◦C, 1H NMR
(400 MHz, d6-DMSO), δ 9.83 (s, 2H), 7.98-7.94 (m, 6H), 7.77 (d, J = 16
Hz, 2H), 7.68 (d, J = 8.0 Hz, 2H), 7.48 (s, 2H), 7.41 (t, J = 8.0 Hz, 2H),
7.09 (dd, J = 8.0, 2.4 Hz, 2H); 13C NMR (100 MHz, CDCl3), δ 189.5,
158.2, 143.3, 139.4, 137.1, 130.3, 129.8, 123.6, 120.8, 120.1, 115.1.
(2E, 2′E)-3,3′-(1,4-phenylene)bis(1-(4-hydroxylphenyl)prop-2-en-1-
one (1c). Yield: 55.8%, yellow powder; mp 219-222 ◦C; 1H NMR (300
Yield: 63.8%, yellow powder; mp 235-237 ◦C; 1H NMR (500 MHz,
(CDCl3), δ 8.06 (dd, J = 8.0 Hz, 4H), 7.81 (d, J = 16.0 Hz, 2H), 7.70 (s,
4H), 7.55 (d, J = 16.0 Hz, 2H), 7.18 (d, J = 8.0 Hz, 4H).
2.3. MTT assay
Human lung carcinoma cells (A549) were from the Shanghai Insti-
tute of Biochemistry and Cell Biology, Chinese Academy of Sciences.
Cells were cultured with RPMI-1640 medium at 37 ◦C in a humidified
atmosphere with 5% CO2. A549 cells were seeded in 96-well plates at a
density of 3 × 103/well and incubated for 24 h. Then the cells were
treated for another 48 h with compounds at the selected concentration.
The next steps were processed according to the reported reference (https
Scheme 1. Molecular structures and synthetics routs of bischalcone analogs.
2